<html>  <head>    <meta  content="text/html; charset=UTF-8"  http-equiv="content-type">    <!--    <style  type="text/css">.lst-kix_c6mggzy9bkhi-7>li{counter-increment:lst-ctn-kix_c6mggzy9bkhi-7}ol.lst-kix_lx3h5q6cjds-3{list-style-type:none}ol.lst-kix_lx3h5q6cjds-2{list-style-type:none}ol.lst-kix_lx3h5q6cjds-5.start{counter-reset:lst-ctn-kix_lx3h5q6cjds-5 0}.lst-kix_qnsw2cr2b80j-8>li:before{content:"\0025a0  "}.lst-kix_ixtk3xu5n7qn-8>li{counter-increment:lst-ctn-kix_ixtk3xu5n7qn-8}ol.lst-kix_c6mggzy9bkhi-3.start{counter-reset:lst-ctn-kix_c6mggzy9bkhi-3 0}.lst-kix_qnsw2cr2b80j-6>li:before{content:"\0025cf  "}.lst-kix_lx3h5q6cjds-8>li{counter-increment:lst-ctn-kix_lx3h5q6cjds-8}.lst-kix_qnsw2cr2b80j-7>li:before{content:"\0025cb  "}.lst-kix_qnsw2cr2b80j-1>li:before{content:"\0025cb  "}ol.lst-kix_ixtk3xu5n7qn-4.start{counter-reset:lst-ctn-kix_ixtk3xu5n7qn-4 0}.lst-kix_qnsw2cr2b80j-0>li:before{content:"\0025cf  "}.lst-kix_qnsw2cr2b80j-2>li:before{content:"\0025a0  "}.lst-kix_qnsw2cr2b80j-5>li:before{content:"\0025a0  "}.lst-kix_qnsw2cr2b80j-4>li:before{content:"\0025cb  "}.lst-kix_qnsw2cr2b80j-3>li:before{content:"\0025cf  "}ul.lst-kix_jw98yuw3jje1-8{list-style-type:none}ul.lst-kix_jw98yuw3jje1-7{list-style-type:none}ol.lst-kix_lx3h5q6cjds-4.start{counter-reset:lst-ctn-kix_lx3h5q6cjds-4 0}ul.lst-kix_jw98yuw3jje1-6{list-style-type:none}ul.lst-kix_jw98yuw3jje1-5{list-style-type:none}ul.lst-kix_jw98yuw3jje1-4{list-style-type:none}ul.lst-kix_jw98yuw3jje1-3{list-style-type:none}ul.lst-kix_jw98yuw3jje1-2{list-style-type:none}ol.lst-kix_c6mggzy9bkhi-2.start{counter-reset:lst-ctn-kix_c6mggzy9bkhi-2 0}ul.lst-kix_jw98yuw3jje1-1{list-style-type:none}ul.lst-kix_jw98yuw3jje1-0{list-style-type:none}ul.lst-kix_qnsw2cr2b80j-2{list-style-type:none}ul.lst-kix_qnsw2cr2b80j-1{list-style-type:none}ol.lst-kix_c6mggzy9bkhi-8.start{counter-reset:lst-ctn-kix_c6mggzy9bkhi-8 0}ul.lst-kix_qnsw2cr2b80j-0{list-style-type:none}ul.lst-kix_qnsw2cr2b80j-6{list-style-type:none}ul.lst-kix_qnsw2cr2b80j-5{list-style-type:none}ul.lst-kix_qnsw2cr2b80j-4{list-style-type:none}ul.lst-kix_qnsw2cr2b80j-3{list-style-type:none}ul.lst-kix_qnsw2cr2b80j-8{list-style-type:none}ul.lst-kix_qnsw2cr2b80j-7{list-style-type:none}.lst-kix_c6mggzy9bkhi-5>li{counter-increment:lst-ctn-kix_c6mggzy9bkhi-5}.lst-kix_jw98yuw3jje1-0>li:before{content:"\0025cf  "}.lst-kix_ixtk3xu5n7qn-1>li{counter-increment:lst-ctn-kix_ixtk3xu5n7qn-1}ol.lst-kix_lx3h5q6cjds-8{list-style-type:none}ol.lst-kix_lx3h5q6cjds-7{list-style-type:none}ol.lst-kix_lx3h5q6cjds-6{list-style-type:none}.lst-kix_ixtk3xu5n7qn-4>li{counter-increment:lst-ctn-kix_ixtk3xu5n7qn-4}ol.lst-kix_lx3h5q6cjds-5{list-style-type:none}.lst-kix_jw98yuw3jje1-1>li:before{content:"\0025cb  "}ol.lst-kix_lx3h5q6cjds-4{list-style-type:none}.lst-kix_jw98yuw3jje1-2>li:before{content:"\0025a0  "}.lst-kix_jw98yuw3jje1-4>li:before{content:"\0025cb  "}.lst-kix_jw98yuw3jje1-3>li:before{content:"\0025cf  "}.lst-kix_lx3h5q6cjds-4>li{counter-increment:lst-ctn-kix_lx3h5q6cjds-4}.lst-kix_cqitspa334da-6>li:before{content:"\0025cf  "}.lst-kix_jw98yuw3jje1-5>li:before{content:"\0025a0  "}ol.lst-kix_c6mggzy9bkhi-7.start{counter-reset:lst-ctn-kix_c6mggzy9bkhi-7 0}.lst-kix_cqitspa334da-4>li:before{content:"\0025cb  "}.lst-kix_jw98yuw3jje1-7>li:before{content:"\0025cb  "}.lst-kix_c6mggzy9bkhi-0>li{counter-increment:lst-ctn-kix_c6mggzy9bkhi-0}ol.lst-kix_ixtk3xu5n7qn-5.start{counter-reset:lst-ctn-kix_ixtk3xu5n7qn-5 0}.lst-kix_cqitspa334da-2>li:before{content:"\0025a0  "}.lst-kix_k1hefpyt8qdu-1>li:before{content:"\0025cb  "}.lst-kix_lx3h5q6cjds-3>li{counter-increment:lst-ctn-kix_lx3h5q6cjds-3}.lst-kix_ixtk3xu5n7qn-3>li{counter-increment:lst-ctn-kix_ixtk3xu5n7qn-3}.lst-kix_cqitspa334da-0>li:before{content:"\0025cf  "}.lst-kix_k1hefpyt8qdu-3>li:before{content:"\0025cf  "}.lst-kix_ixtk3xu5n7qn-0>li:before{content:"" counter(lst-ctn-kix_ixtk3xu5n7qn-0,decimal) ". "}.lst-kix_ixtk3xu5n7qn-2>li:before{content:"" counter(lst-ctn-kix_ixtk3xu5n7qn-2,lower-roman) ". "}.lst-kix_k1hefpyt8qdu-5>li:before{content:"\0025a0  "}.lst-kix_ixtk3xu5n7qn-4>li:before{content:"" counter(lst-ctn-kix_ixtk3xu5n7qn-4,lower-latin) ". "}.lst-kix_lx3h5q6cjds-2>li{counter-increment:lst-ctn-kix_lx3h5q6cjds-2}.lst-kix_lx3h5q6cjds-7>li:before{content:"" counter(lst-ctn-kix_lx3h5q6cjds-7,lower-latin) ". "}.lst-kix_k1hefpyt8qdu-7>li:before{content:"\0025cb  "}.lst-kix_ixtk3xu5n7qn-2>li{counter-increment:lst-ctn-kix_ixtk3xu5n7qn-2}.lst-kix_ixtk3xu5n7qn-8>li:before{content:"" counter(lst-ctn-kix_ixtk3xu5n7qn-8,lower-roman) ". "}.lst-kix_ixtk3xu5n7qn-6>li:before{content:"" counter(lst-ctn-kix_ixtk3xu5n7qn-6,decimal) ". "}.lst-kix_qkescwycupop-7>li:before{content:"\0025cb  "}.lst-kix_c6mggzy9bkhi-1>li{counter-increment:lst-ctn-kix_c6mggzy9bkhi-1}.lst-kix_4vw5dpxrimee-5>li:before{content:"\0025a0  "}.lst-kix_qkescwycupop-1>li:before{content:"\0025cb  "}.lst-kix_c6mggzy9bkhi-4>li:before{content:"" counter(lst-ctn-kix_c6mggzy9bkhi-4,lower-latin) ". "}.lst-kix_c6mggzy9bkhi-6>li:before{content:"" counter(lst-ctn-kix_c6mggzy9bkhi-6,decimal) ". "}.lst-kix_4vw5dpxrimee-3>li:before{content:"\0025cf  "}.lst-kix_4vw5dpxrimee-7>li:before{content:"\0025cb  "}.lst-kix_4vw5dpxrimee-1>li:before{content:"\0025cb  "}.lst-kix_qkescwycupop-5>li:before{content:"\0025a0  "}.lst-kix_c6mggzy9bkhi-0>li:before{content:"" counter(lst-ctn-kix_c6mggzy9bkhi-0,decimal) ". "}.lst-kix_c6mggzy9bkhi-2>li:before{content:"" counter(lst-ctn-kix_c6mggzy9bkhi-2,lower-roman) ". "}.lst-kix_c6mggzy9bkhi-8>li:before{content:"" counter(lst-ctn-kix_c6mggzy9bkhi-8,lower-roman) ". "}ol.lst-kix_ixtk3xu5n7qn-3.start{counter-reset:lst-ctn-kix_ixtk3xu5n7qn-3 0}.lst-kix_qkescwycupop-3>li:before{content:"\0025cf  "}.lst-kix_9dbpnvhyro1-6>li:before{content:"\0025cf  "}.lst-kix_9dbpnvhyro1-8>li:before{content:"\0025a0  "}ol.lst-kix_c6mggzy9bkhi-5.start{counter-reset:lst-ctn-kix_c6mggzy9bkhi-5 0}.lst-kix_lx3h5q6cjds-5>li:before{content:"" counter(lst-ctn-kix_lx3h5q6cjds-5,lower-roman) ". "}.lst-kix_lx3h5q6cjds-3>li:before{content:"" counter(lst-ctn-kix_lx3h5q6cjds-3,decimal) ". "}ul.lst-kix_k1hefpyt8qdu-8{list-style-type:none}ul.lst-kix_k1hefpyt8qdu-7{list-style-type:none}ol.lst-kix_ixtk3xu5n7qn-2.start{counter-reset:lst-ctn-kix_ixtk3xu5n7qn-2 0}.lst-kix_lx3h5q6cjds-1>li:before{content:"\0025cb  "}ul.lst-kix_k1hefpyt8qdu-0{list-style-type:none}.lst-kix_4v4tuo10gdxg-7>li:before{content:"\0025cb  "}ul.lst-kix_k1hefpyt8qdu-2{list-style-type:none}ul.lst-kix_k1hefpyt8qdu-1{list-style-type:none}ul.lst-kix_k1hefpyt8qdu-4{list-style-type:none}.lst-kix_4v4tuo10gdxg-5>li:before{content:"\0025a0  "}ul.lst-kix_k1hefpyt8qdu-3{list-style-type:none}ul.lst-kix_k1hefpyt8qdu-6{list-style-type:none}ul.lst-kix_k1hefpyt8qdu-5{list-style-type:none}.lst-kix_4v4tuo10gdxg-3>li:before{content:"\0025cf  "}.lst-kix_4v4tuo10gdxg-1>li:before{content:"\0025cb  "}.lst-kix_cqitspa334da-8>li:before{content:"\0025a0  "}ol.lst-kix_c6mggzy9bkhi-4.start{counter-reset:lst-ctn-kix_c6mggzy9bkhi-4 0}ol.lst-kix_ixtk3xu5n7qn-1.start{counter-reset:lst-ctn-kix_ixtk3xu5n7qn-1 0}ol.lst-kix_lx3h5q6cjds-2.start{counter-reset:lst-ctn-kix_lx3h5q6cjds-2 0}.lst-kix_c6mggzy9bkhi-6>li{counter-increment:lst-ctn-kix_c6mggzy9bkhi-6}ol.lst-kix_c6mggzy9bkhi-0.start{counter-reset:lst-ctn-kix_c6mggzy9bkhi-0 0}ol.lst-kix_ixtk3xu5n7qn-7{list-style-type:none}ol.lst-kix_ixtk3xu5n7qn-6{list-style-type:none}.lst-kix_9dbpnvhyro1-0>li:before{content:"\0025cf  "}ol.lst-kix_ixtk3xu5n7qn-8{list-style-type:none}ol.lst-kix_ixtk3xu5n7qn-7.start{counter-reset:lst-ctn-kix_ixtk3xu5n7qn-7 0}ul.lst-kix_9dbpnvhyro1-6{list-style-type:none}ul.lst-kix_9dbpnvhyro1-5{list-style-type:none}.lst-kix_9dbpnvhyro1-4>li:before{content:"\0025cb  "}ul.lst-kix_9dbpnvhyro1-4{list-style-type:none}ul.lst-kix_9dbpnvhyro1-3{list-style-type:none}ul.lst-kix_9dbpnvhyro1-2{list-style-type:none}.lst-kix_9dbpnvhyro1-5>li:before{content:"\0025a0  "}ol.lst-kix_c6mggzy9bkhi-6.start{counter-reset:lst-ctn-kix_c6mggzy9bkhi-6 0}ul.lst-kix_9dbpnvhyro1-1{list-style-type:none}ol.lst-kix_lx3h5q6cjds-8.start{counter-reset:lst-ctn-kix_lx3h5q6cjds-8 0}ul.lst-kix_9dbpnvhyro1-0{list-style-type:none}ul.lst-kix_lx3h5q6cjds-0{list-style-type:none}ul.lst-kix_9dbpnvhyro1-8{list-style-type:none}ul.lst-kix_lx3h5q6cjds-1{list-style-type:none}ul.lst-kix_9dbpnvhyro1-7{list-style-type:none}.lst-kix_9dbpnvhyro1-3>li:before{content:"\0025cf  "}ol.lst-kix_ixtk3xu5n7qn-1{list-style-type:none}.lst-kix_9dbpnvhyro1-2>li:before{content:"\0025a0  "}.lst-kix_c6mggzy9bkhi-4>li{counter-increment:lst-ctn-kix_c6mggzy9bkhi-4}ol.lst-kix_ixtk3xu5n7qn-0{list-style-type:none}ol.lst-kix_ixtk3xu5n7qn-3{list-style-type:none}.lst-kix_9dbpnvhyro1-1>li:before{content:"\0025cb  "}ol.lst-kix_ixtk3xu5n7qn-2{list-style-type:none}ol.lst-kix_ixtk3xu5n7qn-5{list-style-type:none}ol.lst-kix_ixtk3xu5n7qn-4{list-style-type:none}ul.lst-kix_qkescwycupop-8{list-style-type:none}.lst-kix_lx3h5q6cjds-7>li{counter-increment:lst-ctn-kix_lx3h5q6cjds-7}ul.lst-kix_qkescwycupop-7{list-style-type:none}ul.lst-kix_qkescwycupop-6{list-style-type:none}ul.lst-kix_qkescwycupop-5{list-style-type:none}ul.lst-kix_qkescwycupop-4{list-style-type:none}ul.lst-kix_qkescwycupop-3{list-style-type:none}ul.lst-kix_qkescwycupop-2{list-style-type:none}ul.lst-kix_qkescwycupop-1{list-style-type:none}ul.lst-kix_qkescwycupop-0{list-style-type:none}ul.lst-kix_4vw5dpxrimee-6{list-style-type:none}ul.lst-kix_cqitspa334da-5{list-style-type:none}ul.lst-kix_4vw5dpxrimee-5{list-style-type:none}ul.lst-kix_cqitspa334da-6{list-style-type:none}ul.lst-kix_4vw5dpxrimee-4{list-style-type:none}ul.lst-kix_cqitspa334da-3{list-style-type:none}ul.lst-kix_4vw5dpxrimee-3{list-style-type:none}ul.lst-kix_cqitspa334da-4{list-style-type:none}ul.lst-kix_4vw5dpxrimee-2{list-style-type:none}.lst-kix_c6mggzy9bkhi-8>li{counter-increment:lst-ctn-kix_c6mggzy9bkhi-8}ol.lst-kix_lx3h5q6cjds-3.start{counter-reset:lst-ctn-kix_lx3h5q6cjds-3 0}ul.lst-kix_4vw5dpxrimee-1{list-style-type:none}ul.lst-kix_4vw5dpxrimee-0{list-style-type:none}ul.lst-kix_cqitspa334da-7{list-style-type:none}ul.lst-kix_cqitspa334da-8{list-style-type:none}ol.lst-kix_c6mggzy9bkhi-1.start{counter-reset:lst-ctn-kix_c6mggzy9bkhi-1 0}ol.lst-kix_ixtk3xu5n7qn-0.start{counter-reset:lst-ctn-kix_ixtk3xu5n7qn-0 0}.lst-kix_c6mggzy9bkhi-2>li{counter-increment:lst-ctn-kix_c6mggzy9bkhi-2}ul.lst-kix_cqitspa334da-1{list-style-type:none}ul.lst-kix_cqitspa334da-2{list-style-type:none}ul.lst-kix_cqitspa334da-0{list-style-type:none}.lst-kix_ixtk3xu5n7qn-7>li{counter-increment:lst-ctn-kix_ixtk3xu5n7qn-7}ol.lst-kix_ixtk3xu5n7qn-6.start{counter-reset:lst-ctn-kix_ixtk3xu5n7qn-6 0}ul.lst-kix_4vw5dpxrimee-8{list-style-type:none}ul.lst-kix_4vw5dpxrimee-7{list-style-type:none}.lst-kix_cqitspa334da-7>li:before{content:"\0025cb  "}.lst-kix_jw98yuw3jje1-6>li:before{content:"\0025cf  "}.lst-kix_jw98yuw3jje1-8>li:before{content:"\0025a0  "}.lst-kix_cqitspa334da-3>li:before{content:"\0025cf  "}.lst-kix_cqitspa334da-5>li:before{content:"\0025a0  "}ol.lst-kix_ixtk3xu5n7qn-8.start{counter-reset:lst-ctn-kix_ixtk3xu5n7qn-8 0}ol.lst-kix_c6mggzy9bkhi-5{list-style-type:none}.lst-kix_k1hefpyt8qdu-0>li:before{content:"\0025cf  "}ol.lst-kix_c6mggzy9bkhi-6{list-style-type:none}ol.lst-kix_c6mggzy9bkhi-7{list-style-type:none}ol.lst-kix_c6mggzy9bkhi-8{list-style-type:none}.lst-kix_k1hefpyt8qdu-4>li:before{content:"\0025cb  "}ol.lst-kix_c6mggzy9bkhi-0{list-style-type:none}ol.lst-kix_c6mggzy9bkhi-1{list-style-type:none}.lst-kix_cqitspa334da-1>li:before{content:"\0025cb  "}.lst-kix_k1hefpyt8qdu-2>li:before{content:"\0025a0  "}ol.lst-kix_c6mggzy9bkhi-2{list-style-type:none}ol.lst-kix_c6mggzy9bkhi-3{list-style-type:none}ol.lst-kix_c6mggzy9bkhi-4{list-style-type:none}.lst-kix_k1hefpyt8qdu-8>li:before{content:"\0025a0  "}.lst-kix_ixtk3xu5n7qn-5>li{counter-increment:lst-ctn-kix_ixtk3xu5n7qn-5}.lst-kix_ixtk3xu5n7qn-1>li:before{content:"" counter(lst-ctn-kix_ixtk3xu5n7qn-1,lower-latin) ". "}.lst-kix_k1hefpyt8qdu-6>li:before{content:"\0025cf  "}.lst-kix_ixtk3xu5n7qn-3>li:before{content:"" counter(lst-ctn-kix_ixtk3xu5n7qn-3,decimal) ". "}.lst-kix_lx3h5q6cjds-5>li{counter-increment:lst-ctn-kix_lx3h5q6cjds-5}.lst-kix_lx3h5q6cjds-8>li:before{content:"" counter(lst-ctn-kix_lx3h5q6cjds-8,lower-roman) ". "}.lst-kix_ixtk3xu5n7qn-5>li:before{content:"" counter(lst-ctn-kix_ixtk3xu5n7qn-5,lower-roman) ". "}.lst-kix_qkescwycupop-6>li:before{content:"\0025cf  "}.lst-kix_qkescwycupop-8>li:before{content:"\0025a0  "}.lst-kix_ixtk3xu5n7qn-7>li:before{content:"" counter(lst-ctn-kix_ixtk3xu5n7qn-7,lower-latin) ". "}ul.lst-kix_4v4tuo10gdxg-0{list-style-type:none}.lst-kix_4vw5dpxrimee-6>li:before{content:"\0025cf  "}ul.lst-kix_4v4tuo10gdxg-1{list-style-type:none}.lst-kix_qkescwycupop-2>li:before{content:"\0025a0  "}.lst-kix_4vw5dpxrimee-4>li:before{content:"\0025cb  "}.lst-kix_4vw5dpxrimee-8>li:before{content:"\0025a0  "}.lst-kix_c6mggzy9bkhi-3>li:before{content:"" counter(lst-ctn-kix_c6mggzy9bkhi-3,decimal) ". "}.lst-kix_c6mggzy9bkhi-7>li:before{content:"" counter(lst-ctn-kix_c6mggzy9bkhi-7,lower-latin) ". "}ol.lst-kix_lx3h5q6cjds-7.start{counter-reset:lst-ctn-kix_lx3h5q6cjds-7 0}ul.lst-kix_4v4tuo10gdxg-8{list-style-type:none}.lst-kix_4vw5dpxrimee-2>li:before{content:"\0025a0  "}ul.lst-kix_4v4tuo10gdxg-6{list-style-type:none}ul.lst-kix_4v4tuo10gdxg-7{list-style-type:none}ul.lst-kix_4v4tuo10gdxg-4{list-style-type:none}ul.lst-kix_4v4tuo10gdxg-5{list-style-type:none}.lst-kix_qkescwycupop-4>li:before{content:"\0025cb  "}ul.lst-kix_4v4tuo10gdxg-2{list-style-type:none}.lst-kix_c6mggzy9bkhi-1>li:before{content:"" counter(lst-ctn-kix_c6mggzy9bkhi-1,lower-latin) ". "}ul.lst-kix_4v4tuo10gdxg-3{list-style-type:none}.lst-kix_9dbpnvhyro1-7>li:before{content:"\0025cb  "}.lst-kix_lx3h5q6cjds-6>li{counter-increment:lst-ctn-kix_lx3h5q6cjds-6}.lst-kix_lx3h5q6cjds-6>li:before{content:"" counter(lst-ctn-kix_lx3h5q6cjds-6,decimal) ". "}.lst-kix_4vw5dpxrimee-0>li:before{content:"\0025cf  "}.lst-kix_c6mggzy9bkhi-3>li{counter-increment:lst-ctn-kix_c6mggzy9bkhi-3}.lst-kix_ixtk3xu5n7qn-0>li{counter-increment:lst-ctn-kix_ixtk3xu5n7qn-0}.lst-kix_lx3h5q6cjds-4>li:before{content:"" counter(lst-ctn-kix_lx3h5q6cjds-4,lower-latin) ". "}.lst-kix_qkescwycupop-0>li:before{content:"\0025cf  "}.lst-kix_ixtk3xu5n7qn-6>li{counter-increment:lst-ctn-kix_ixtk3xu5n7qn-6}.lst-kix_lx3h5q6cjds-0>li:before{content:"\0025cf  "}.lst-kix_lx3h5q6cjds-2>li:before{content:"" counter(lst-ctn-kix_lx3h5q6cjds-2,lower-roman) ". "}.lst-kix_4v4tuo10gdxg-8>li:before{content:"\0025a0  "}.lst-kix_4v4tuo10gdxg-6>li:before{content:"\0025cf  "}.lst-kix_4v4tuo10gdxg-2>li:before{content:"\0025a0  "}.lst-kix_4v4tuo10gdxg-4>li:before{content:"\0025cb  "}.lst-kix_4v4tuo10gdxg-0>li:before{content:"\0025cf  "}.lst-kix_c6mggzy9bkhi-5>li:before{content:"" counter(lst-ctn-kix_c6mggzy9bkhi-5,lower-roman) ". "}ol.lst-kix_lx3h5q6cjds-6.start{counter-reset:lst-ctn-kix_lx3h5q6cjds-6 0}ol{margin:0;padding:0}table td,table th{padding:0}.c4{background-color:#ffffff;color:#333333;vertical-align:sub;font-size:9pt;font-family:"Times New Roman"}.c2{margin-left:36pt;orphans:2;widows:2;padding-left:0pt}.c6{orphans:2;widows:2;height:11pt}.c9{background-color:#ffffff;font-size:9pt;color:#333333}.c24{background-color:#ffffff;max-width:511.2pt;padding:36pt 50.4pt 36pt 50.4pt}.c19{color:#1155cc;text-decoration:underline}.c7{orphans:2;widows:2}.c8{font-size:18pt;text-decoration:underline}.c16{color:inherit;text-decoration:inherit}.c10{padding-top:14pt;padding-bottom:4pt}.c22{background-color:#ffffff;color:#121212}.c18{padding:0;margin:0}.c3{font-size:12pt}.c20{text-decoration:underline}.c11{font-family:"Times New Roman"}.c5{vertical-align:sub}.c15{vertical-align:super}.c0{font-style:italic}.c12{font-size:9pt}.c14{page-break-after:avoid}.c1{font-weight:bold}.c17{font-size:18pt}.c21{text-align:center}.c23{font-size:10pt}.c13{color:#000000}.title{padding-top:0pt;color:#000000;font-size:26pt;padding-bottom:3pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}.subtitle{padding-top:0pt;color:#666666;font-size:15pt;padding-bottom:16pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}li{color:#000000;font-size:11pt;font-family:"Arial"}p{margin:0;color:#000000;font-size:11pt;font-family:"Arial"}h1{padding-top:14pt;color:#000000;text-decoration:underline;font-size:18pt;padding-bottom:3pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}h2{padding-top:12pt;color:#000000;font-weight:bold;font-size:14pt;padding-bottom:0pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}h3{padding-top:6pt;color:#434343;font-weight:bold;font-size:13pt;padding-bottom:0pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}h4{padding-top:14pt;color:#666666;font-size:12pt;padding-bottom:4pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}h5{padding-top:12pt;color:#666666;font-size:11pt;padding-bottom:4pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}h6{padding-top:12pt;color:#666666;font-size:11pt;padding-bottom:4pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;font-style:italic;orphans:2;widows:2;text-align:left}</style>		-->    <title>about</title>  </head>  <body>    <p  class="c6"><span></span></p>    <span>Commonly, relative cell count at the end of treatment is used to      assess drug response. Across a range of concentrations, the measured cell      coun</span><span>t</span><span>&nbsp;or a surrogate of it (e.g.      measurement of ATP using CellTiter-Glo®) is normalized to the cell count      of DMSO-treated controls grown on the same plate under the same      conditions. For each condition (combination of cell line, drug, and drug      concentration), we define the relative cell count as </span><span  class="c11 c0">x(c)/x</span><span       class="c11 c5 c0">ctrl</span><span>,      where </span><span  class="c11 c0">x(c)</span><span>&nbsp;is the count in      the presence of drug and </span><span  class="c11 c0">x</span><span  class="c11 c5 c0">ctrl</span><span>&nbsp;is
      the 50%-trimmed mean of the count for control cells. Based on a sigmoidal      curve fitted to the relative cell count across different concentrations,      one can define:</span>    <p  class="c6"><span></span></p>    <ul  class="c18 lst-kix_qnsw2cr2b80j-0 start">      <li  class="c2"><span  class="c0">IC</span><span  class="c5 c0">50</span><span>&nbsp;(50%
          relative cell count), which is the most commonly used metric but one          that can only be defined if the relative cell count decreases during          the assay to </span><span>below</span><span>&nbsp;50% of the starting          value;</span></li>      <li  class="c2"><span  class="c0">EC</span><span  class="c5 c0">50</span><span>&nbsp;(half-point
          of the sigmoidal curve);</span></li>      <li  class="c2"><span  class="c0">E</span><span  class="c5 c0">inf</span><span>&nbsp;(the
          asymptotic efficacy), which differs from </span><span  class="c0">E</span><span           class="c5 c0">max</span><span>&nbsp;(the
          maximal measured efficacy); and</span></li>      <li  class="c2"><span  class="c0">AUC </span><span>(area under, or over,          the curve), which captures both </span><span  class="c0">IC</span><span           class="c5 c0">50</span><span>&nbsp;and
          </span><span  class="c0">E</span><span  class="c5 c0">max</span><span>&nbsp;to
          some extent and is more robust to experimental noise than other          metrics.</span></li>    </ul>    <p  class="c6"><span></span></p>    <p  class="c7"><span>More details on dose-response assays and traditional        metrics can be found in</span><span>&nbsp;Sebaugh et al. (2010).</span><span>&nbsp;</span></p>    <p  class="c6"><span></span></p>    <p  class="c7 c21"><span  style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 536.99px; height: 249.50px;"><img           alt=""           src="images/image07.png"           style="width: 536.99px; height: 249.50px; margin-left: 0.00px; margin-top: 0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"           title=""></span></p>    <p  class="c7"><span  class="c12 c1">Examples of dose-response curves based        on relative cell count.</span><span  class="c12">&nbsp;In the first        example (left), a strong drug response results in an </span><span  class="c0 c12">E</span><span         class="c5 c0 c12">inf</span><span         class="c0 c12">&nbsp;</span><span         class="c12">close
        to 0 and a well-defined </span><span  class="c0 c12">IC</span><span  class="c5 c0 c12">50</span><span         class="c12">.        In the second (right), a partial response results in an </span><span  class="c0 c12">E</span><span         class="c5 c0 c12">inf</span><span         class="c12">&nbsp;above
        0.5 and an undefined </span><span  class="c0 c12">IC</span><span  class="c5 c0 c12">50</span><span         class="c12">.</span></p>    <p  class="c6"><span></span></p>    <p  class="c7"><span>-----</span></p>    <p  class="c6"><span></span></p>    <h1  class="c7 c14"  id="h.xnwbiv8sjyzq"><span>About GR metrics</span></h1>    <p  class="c7"><span>As an alternative to traditional metrics, we propose to        use GR metrics, which are based on inhibition of the growth rate over        the course of the assay and are independent of the division rate of the        assayed cell lines.</span></p>    <p  class="c6"><span></span></p>    <p  class="c7"><span>Growth can be estimated at different concentrations        based on the cell count at the time of treatment (</span><span  class="c0">x</span><span         class="c5 c0">0</span><span>),
        the cell count in the untreated control (</span><span  class="c0">x</span><span         class="c5 c0">ctrl</span><span>),
        and the cell count after treatment at concentration </span><span  class="c0">c</span><span>&nbsp;(</span><span         class="c0">x(c)</span><span>):
        </span></p>    <p  class="c7"><span  style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 415.00px; height: 98.00px;"><img           alt=""           src="images/image04.png"           style="width: 415.00px; height: 98.00px; margin-left: 0.00px; margin-top: 0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"           title=""></span></p>    <p  class="c7"><span>This equation assumes exponential growth and constant        growth inhibition by the drug. Many phenomena such as drug efflux,        homeostasis and adaptation can result in non-exponential growth. In such        cases, time course assays and time-dependent GR values are better suited        to evaluating drug response. Given measurements of cell count at        different time points, time-dependent GR values are defined as:</span></p>    <p  class="c7"><span  style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 653.00px; height: 111.00px;"><img           alt=""           src="images/image10.png"           style="width: 653.00px; height: 111.00px; margin-left: 0.00px; margin-top: 0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"           title=""></span></p>    <p  class="c6"><span></span></p>    <p  class="c7"><span  style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 681.60px; height: 218.67px;"><img           alt=""           src="images/image02.png"           style="width: 681.60px; height: 218.67px; margin-left: 0.00px; margin-top: 0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"           title=""></span></p>    <p  class="c7"><span  class="c1 c9">Different methods can be used to        evaluate GR values: </span><span  class="c9">(left) Conceptual approach        based on growth rates (</span><span  class="c9 c11 c0">k</span><span  class="c0 c4">0</span><span         class="c9">&nbsp;and</span><span         class="c9 c11 c0">&nbsp;k(c)</span><span         class="c9">);
        (middle) fixed-interval approach based on cell number at the start (x0)        and end of the experiment (</span><span  class="c9 c11 c0">x</span><span         class="c4 c0">ctrl</span><span         class="c9">&nbsp;and
        </span><span  class="c9 c11 c0">x(c)</span><span  class="c9">); and        (right) time-dependent approach based on cell count before and after a        time interval </span><span  class="c9 c11 c0">2 × 𝚫t (x(c, t ± 𝚫t))</span><span         class="c9">.</span></p>    <p  class="c6"><span></span></p>    <p  class="c7"><span  class="c0">GR(c) </span><span>values (or        time-dependent </span><span  class="c0">GR(c,t)</span><span>&nbsp;values
        at a given time </span><span  class="c0">t</span><span>)</span><span>&nbsp;across
        a range of concentrations are fitted to a sigmoidal curve:</span></p>    <p  class="c7"><span  style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 634.30px; height: 97.66px;"><img           alt=""           src="images/image05.png"           style="width: 634.30px; height: 97.66px; margin-left: 0.00px; margin-top: 0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"           title=""></span></p>    <p  class="c7"><span>where the fitted parameters are:</span></p>    <ul  class="c18 lst-kix_cqitspa334da-0 start">      <li  class="c2"><span  class="c0 c1">GR</span><span  class="c5 c0 c1">inf</span><span>:          the effect of the drug at infinite concentration (</span><span  class="c0">GR</span><span           class="c5 c0">inf</span><span           class="c0">&nbsp;=
          GR(c→∞)</span><span>). </span><span  class="c0">GR</span><span  class="c5 c0">inf</span><span>&nbsp;lies
          between –1 and 1. Negative values correspond to cytotoxic responses          (i.e., induction of cell death), and a value of 0 corresponds to a          fully cytostatic response.</span></li>      <li  class="c2"><span  class="c0 c1">h</span><span  class="c5 c0 c1">GR</span><span>:          the Hill coefficient of the fitted curve, which reflects how steep the          dose-response curve is. In practice, we typically constrain </span><span           class="c0">h</span><span           class="c5 c0">GR</span><span>&nbsp;to
          a value between 0.1 and 5.</span></li>      <li  class="c2"><span  class="c0 c1">GEC</span><span  class="c5 c0 c1">50</span><span>:          the concentration at half-maximal effect. To avoid artefacts in curve          fitting we constrain </span><span  class="c0">GEC</span><span  class="c5 c0">50</span><span>&nbsp;to
          be within two orders of magnitude higher and lower than the          experimentally tested concentration range. (In practice, this is          usually about 10</span><span  class="c15">-7</span><span>&nbsp;to 10</span><span           class="c15">3</span><span>&nbsp;μM.)</span></li>    </ul>    <p  class="c6"><span></span></p>    <p  class="c7"><span>If the fit of the curve is not significantly better        than that of a flat curve (i.e., </span><span  class="c0">GR(c) ≡ GR</span><span         class="c5 c0">inf</span><span>)        based on an F-test with cutoff of p = 0.05, the response is considered        flat, and the parameter </span><span  class="c0">GEC</span><span  class="c5 c0">50</span><span>&nbsp;is
        set to 0.</span></p>    <p  class="c6"><span></span></p>    <p  class="c7"><span>If time-dependent </span><span  class="c0">GR(c,t)</span><span>&nbsp;values
        are used, GR metrics can be estimated at a different time points to        study how sensitivity evolves over time.</span></p>    <h3  class="c7 c10"  id="h.e6m8nf1dasrb"><span  class="c13">Inferred drug        response metrics</span></h3>    <p  class="c7"><span>The </span><span  class="c0">GR</span><span  class="c5 c0">50</span><span>&nbsp;value
        is the concentration of drug at which </span><span  class="c0">GR</span><span>(</span><span         class="c0">c        = GR</span><span  class="c5 c0">50</span><span>)</span><span  class="c0">&nbsp;=
        0.5</span><span>. If the value for </span><span  class="c0">GR</span><span         class="c5 c0">inf</span><span>&nbsp;is
        above 0.5, the </span><span  class="c0">GR</span><span  class="c5 c0">50</span><span>&nbsp;value
        is not defined and is therefore set to </span><span  class="c0">+∞</span><span>.        By extension, other thresholds can be defined in a similar manner. For        example, </span><span  class="c0">GR</span><span  class="c5 c0">100</span><span>&nbsp;corresponds
        to the concentration at which a drug is fully cytostatic: </span><span         class="c0">GR</span><span>(</span><span         class="c0">c        = GR</span><span  class="c5 c0">100</span><span>)</span><span  class="c0">&nbsp;=
        0</span><span>.</span></p>    <p  class="c6"><span></span></p>    <p  class="c7"><span  class="c0">GR</span><span  class="c5 c0">max </span><span>is
        the maximum effect of the drug at the highest tested concentration. It        lies between –1 and 1. A value of 0 corresponds to a fully cytostatic        response, and negative values correspond to a cytotoxic response. </span><span         class="c0">GR</span><span         class="c5 c0">max</span><span>&nbsp;can
        be estimated from the fitted curve or obtained directly from        experimental data. (We often do the later.)</span></p>    <p  class="c6"><span></span></p>    <p  class="c7"><span>For time course data, all metrics are evaluated at each        time point individually.</span></p>    <h3  class="c7 c10"  id="h.1pf15leifx2n"><span  class="c13">Area under the        curve and over the curve (GR</span><span  class="c5 c13">AOC</span><span         class="c13">)</span></h3>    <p  class="c7"><span>Another common metric for quantifying dose response is        the area under the response curve (AUC), which is based on integrating        the dose-response curve over the range of tested concentrations. In the        case of </span><span  class="c0">GR</span><span>&nbsp;curves, which can        have negative values, it is more intuitive to use the area over the        curve:</span></p>    <p  class="c7"><span  style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 681.60px; height: 61.33px;"><img           alt=""           src="images/image08.png"           style="width: 681.60px; height: 61.33px; margin-left: 0.00px; margin-top: 0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"           title=""></span></p>    <p  class="c7"><span>where </span><span  class="c0">GR</span><span>(</span><span         class="c0">c</span><span         class="c5 c0">i</span><span>)        are measured GR values at discrete concentrations </span><span  class="c0">c</span><span         class="c5 c0">i</span><span>.      </span><span  class="c0">GR</span><span  class="c0 c5">AOC</span><span  class="c0">&nbsp;</span><span>has
        the benefit that, in the case of no response, it has a value of 0. It is        important to note that </span><span  class="c0">GR</span><span  class="c5 c0">AOC</span><span>&nbsp;values
        (like conventional AUC) can only be used to compare responses evaluated        across the same drug concentration range.</span></p>    <p  class="c6"><span></span></p>    <p  class="c7"><span>The </span><span  class="c0">GR</span><span  class="c5 c0">AOC</span><span>&nbsp;value
        captures variation in potency and efficacy at the same time. The        calculation of </span><span  class="c0">GR</span><span  class="c5 c0">AOC</span><span>&nbsp;at
        discrete (experimentally determined) concentrations has the advantage        that it does not require curve fitting and is therefore free of fitting        artifacts. This is especially useful for assays where fewer than five        concentrations are measured and curve fitting is unreliable. </span><span         class="c0">GR</span><span         class="c5 c0">AOC</span><span>&nbsp;values
        are also more robust to experimental noise than metrics derived from        curve fitting; e.g. </span><span  class="c0">GR</span><span  class="c5 c0">max</span><span>&nbsp;is
        particularly sensitive to outlier values when directly obtained from        data.</span></p>    <p  class="c6"><span></span></p>    <p  class="c6"><span></span></p>    <p  class="c6"><span></span></p>    <p  class="c7"><span  style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 642.00px; height: 612.00px;"><img           alt=""           src="images/image01.png"           style="width: 642.00px; height: 612.00px; margin-left: 0.00px; margin-top: 0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"           title=""></span></p>    <p  class="c7"><span  class="c9 c1">Examples of dose-response curves and        fits.</span><span  class="c9">&nbsp;The upper panels depict strong        responses to drugs for which all sensitivity parameters can be defined.        In contrast, in the case shown in the lower left panel, </span><span  class="c9 c0">GR</span><span         class="c9 c5 c0">inf</span><span         class="c9">&nbsp;is
        above 0.5, so </span><span  class="c9 c0">GR</span><span  class="c9 c5 c0">50</span><span         class="c9">&nbsp;cannot
        be defined (and thus is set to ∞). In the case shown in the lower right        panel, the response is weak and noisy, so the sigmoidal fit is not        significant, and a straight flat line is fitted. Nevertheless, only </span><span         class="c9 c0">GR</span><span         class="c9 c5 c0">AUC</span><span         class="c9">&nbsp;and
        </span><span  class="c9 c0">GR</span><span  class="c9 c5 c0">inf</span><span         class="c9">&nbsp;can
        be defined.</span></p>    <p  class="c7"><span  class="c23">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></p>    <h1  class="c7 c14"  id="h.jxm7uvdes7b1"><span>Exploration Tool</span></h1>    <p  class="c7"><span>We used computer simulation (see below) to model drug        response by three idealized cell lines having identical sensitivity to a        partial, or complete </span><span>cytostatic</span><span>&nbsp;drug        (i.e., a drug that arrests but does not kill cells), or a cytotoxic drug        (i.e., a drug that kills cells) and different division times (</span><span         class="c0">T</span><span         class="c5 c0">d</span><span>).
        For example, the lower quartile, median, and upper quartile of the        division times for breast cancer cell lines has been reported as 1.8,        2.4, or 3.9 days, respectively (</span><span>Heiser et al. (2012)</span><span>).
        These values are similar to those of NCI-60 cells. In a slow-dividing        cell line (</span><span  class="c0">T</span><span  class="c5 c0">d</span><span>&nbsp;&gt;
        3.9 d), the total number of cells does not double in a typical three-day        assay; thus </span><span  class="c0">E</span><span  class="c5 c0">max</span><span>&nbsp;≥
        0.5 and </span><span  class="c0">IC</span><span  class="c5 c0">50</span><span>&nbsp;are
        undefined. In the case of the two faster-growing cell lines, </span><span         class="c0">IC</span><span         class="c5 c0">50</span><span>&nbsp;and
        </span><span  class="c0">E</span><span  class="c5 c0">max</span><span>&nbsp;values
        fall as division rate increases simply because cell number (or CTG        value) is normalized to a drug-naïve control in which cell number        increases as division time falls. </span></p>    <p  class="c6"><span></span></p>    <p  class="c7 c21"><span  style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 661.30px; height: 260.70px;"><img           alt="Screen Shot 2016-03-25 at 2.43.16 PM.png"           src="images/image03.png"           style="width: 661.30px; height: 260.70px; margin-left: 0.00px; margin-top: 0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"           title=""></span></p>    <p  class="c7"><span  class="c12 c1">Exploration Tool.</span><span  class="c12">&nbsp;This
        interactive model of drug response illustrates the dependency of        relative cell count and </span><span  class="c0 c12">IC</span><span  class="c5 c0 c12">50</span><span         class="c0 c12">/E</span><span         class="c5 c0 c12">ma</span><span         class="c5 c12">x</span><span         class="c12">&nbsp;metrics
        on cell division time. Adjust the sliders to alter the model parameters,        or select one of buttons to display the output of the model for a        defined drug response profile (cytostatic, partial cytostatic, or        cytotoxic). (left) Normalized cell count over time at different        concentrations of drug; (middle) the resulting IC curve and IC metrics;        (right) the resulting GR curve and GR metrics.</span></p>    <p  class="c6"><span  class="c12"></span></p>    <p  class="c6"><span  class="c12"></span></p>    <p  class="c7"><span>To simulate the effect of division time on </span><span         class="c0">GR</span><span>&nbsp;and
        conventional drug-response metrics under different assumptions about the        degree of cytostasis or cell killing, we developed a theoretical model        of drug response. To the first approximation, cell growth can be        considered exponential, with drugs either decreasing the division rate        or killing cells in a cell cycle-dependent manner:</span></p>    <p  class="c7"><span>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;        &nbsp; &nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span         style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 681.60px; height: 142.67px;"><img           alt=""           src="images/image06.png"           style="width: 681.60px; height: 142.67px; margin-left: 0.00px; margin-top: 0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"           title=""></span></p>    <p  class="c7"><span>where </span><span  class="c0">x</span><span>&nbsp;is        the cell count, </span><span  class="c0">k</span><span>&nbsp;is the        untreated growth rate (per day), </span><span  class="c0">c</span><span>&nbsp;is
        the drug concentration, </span><span  class="c0">S</span><span  class="c5 c0">M</span><span>&nbsp;is
        the maximal inhibitory effect,</span><span  class="c0">&nbsp;SC</span><span         class="c5 c0">50</span><span>&nbsp;is
        the concentration at half-maximal effect of drug, and</span><span  class="c0">&nbsp;h</span><span>&nbsp;is
        the Hill coefficient. The growth rate </span><span  class="c11 c0">k</span><span>&nbsp;corresponds
        to the division rate </span><span  class="c11 c0">k</span><span  class="c11 c5 c0">0</span><span>&nbsp;as
        </span><span  class="c11 c0">k </span><span  class="c11">= ln(2)⋅</span><span         class="c11 c0">k</span><span         class="c11 c5 c0">0</span><span         class="c11">&nbsp;=
        ln(2)/</span><span  class="c11 c0">T</span><span  class="c11 c5 c0">d</span><span>,        where </span><span  class="c11 c0">T</span><span  class="c5 c0 c11">d</span><span>&nbsp;is
        the division time. </span><span  class="c0">S</span><span  class="c5 c0">M</span><span>&nbsp;can
        be larger than 1 to account for drugs inducing cell death at a specific        phase of the cell cycle. </span></p>    <p  class="c6"><span></span></p>    <p  class="c7"><span>Integrating these equations for an assay of </span><span         class="c0">t</span><span>&nbsp;days
        yields the cell count at concentration </span><span  class="c0">c</span><span>:</span></p>    <p  class="c7"><span>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;        &nbsp; &nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span         style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 681.60px; height: 118.67px;"><img           alt=""           src="images/image11.png"           style="width: 681.60px; height: 118.67px; margin-left: 0.00px; margin-top: 0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"           title=""></span></p>    <p  class="c7"><span>where </span><span  class="c11 c0">x</span><span  class="c11 c5 c0">0</span><span         class="c11">&nbsp;=
        </span><span  class="c11 c0">x</span><span  class="c11">(</span><span  class="c11 c0">t</span><span         class="c11">&nbsp;=
        </span><span  class="c11 c0">0</span><span  class="c11">)</span><span>&nbsp;is
        the cell number at the time of treatment. Thus, the relative cell count        is:</span></p>    <p  class="c7"><span>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;        &nbsp; &nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span         class="c11">&nbsp;</span><span>&nbsp;
        </span><span  style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 681.60px; height: 80.00px;"><img           alt=""           src="images/image00.png"           style="width: 681.60px; height: 80.00px; margin-left: 0.00px; margin-top: 0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"           title=""></span><span>&nbsp;where
        </span><span  class="c0">x</span><span  class="c5 c0">ctrl</span><span>&nbsp;</span><span         class="c0">≡        x(0)</span><span>, and the normalized growth rate inhibition (</span><span         class="c0">GR</span><span>&nbsp;value)
        is:</span></p>    <p  class="c7"><span>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;        &nbsp; &nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span><span         style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 681.60px; height: 85.33px;"><img           alt=""           src="images/image09.png"           style="width: 681.60px; height: 85.33px; margin-left: 0.00px; margin-top: 0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);"           title=""></span></p>    <p  class="c7"><span  class="c3">This equation for </span><span  class="c3 c0">GR(c)</span><span         class="c3">&nbsp;is
        independent of the length of the assay </span><span  class="c3 c11 c0">t</span><span         class="c3">&nbsp;and
        the untreated growth rate </span><span  class="c3 c0">k</span><span  class="c3">,</span><span         class="c3 c0">&nbsp;</span><span         class="c3">and,
        thus, the metrics </span><span  class="c3 c0">GR</span><span  class="c3 c5 c0">50</span><span         class="c3">,      </span><span  class="c3 c0">GR</span><span  class="c3 c5 c0">max</span><span         class="c3">,      </span><span  class="c3 c0">GR</span><span  class="c3 c5 c0">AOC</span><span         class="c3">,        and </span><span  class="c3 c0">h</span><span  class="c3 c5 c0">GR</span><span         class="c3">&nbsp;are
        also independent of </span><span  class="c3 c11 c0">t</span><span  class="c3">&nbsp;and
        </span><span  class="c3 c11 c0">k</span><span  class="c3">. </span></p>    <p  class="c6"><span  class="c12"></span></p>    <p  class="c6"><span  class="c12"></span></p>    <p  class="c7"><span>-----</span></p>    <p  class="c6"><span></span></p>    <h1  class="c7 c14"  id="h.nmbmnok8t8li"><span>Online GR Calculator</span></h1>    <h2  class="c7 c14"  id="h.jtb73mccvg4m"><span>About the GR calculator</span></h2>    <p  class="c7"><span>Through the accompanying webpages we provide online        tools that allow users to upload their own endpoint data, calculate the        corresponding GR values and GR metrics, and compare their results across        the variables in the assay, such as cell line, agent (drug), time and        replicate. Matlab and Python scripts for calculating GR value and GR        metrics also are available through the</span><span><a  class="c16"  href="https://www.google.com/url?q=https://github.com/sorgerlab/gr50_tools&amp;sa=D&amp;ust=1460307175306000&amp;usg=AFQjCNGnzP0cznqu1uu8aBaYsRaeFexq1w">&nbsp;</a></span><span         class="c19"><a           class="c16"           href="https://www.google.com/url?q=https://github.com/sorgerlab/gr50_tools&amp;sa=D&amp;ust=1460307175307000&amp;usg=AFQjCNF5CbyKf_F08cIF1u1nPfiaqZi6Zw">Sorger
          lab GR50 Tools Git repository</a></span><span>.</span></p>    <h2  class="c7 c14"  id="h.7uaaomtim0py"><span>Input data:</span></h2>    <p  class="c7"><span>The input .tsv file(s) must have the following column        headers (first row of the file):</span></p>    <ul  class="c18 lst-kix_4vw5dpxrimee-0 start">      <li  class="c2"><span  class="c1">concentration</span><span>&nbsp;=          concentration of the perturbagen on which dose-response curves will be          evaluated</span></li>    </ul>    <ul  class="c18 lst-kix_9dbpnvhyro1-0 start">      <li  class="c2"><span  class="c1">cell count</span><span>&nbsp;in a column          labeled </span><span  class="c0">cell_count </span><span>=</span><span>&nbsp;the
          measure of cell number (or a surrogate of cell number such as          CellTiter-Glo® staining) after treatment</span></li>      <li  class="c2"><span  class="c1">control cell count</span><span>&nbsp;in          a column labeled </span><span  class="c0">cell_count__ctrl</span><span>&nbsp;
          = the measure of cell number in control (e.g. DMSO-treated) wells from          the same plate</span></li>      <li  class="c2"><span  class="c1">time 0 cell count</span><span>&nbsp;in a          column labeled </span><span  class="c0">cell_count__time0 </span><span>=          the measure of cell number in untreated wells grown in parallel until          the time of treatment</span></li>    </ul>    <p  class="c7"><span>&nbsp;</span></p>    <p  class="c7"><span>All other columns will be treated as additional key        variables (e.g. </span><span  class="c0">cell_line</span><span>, </span><span         class="c0">drug</span><span>,      </span><span  class="c0">time</span><span>, </span><span  class="c0">replicate</span><span>).</span></p>    <p  class="c6"><span></span></p>    <h2  class="c7 c14"  id="h.57wjmingbrln"><span>Calculated metrics: </span></h2>    <p  class="c7"><span>The following GR metrics are calculated: </span></p>    <ul  class="c18 lst-kix_jw98yuw3jje1-0 start">      <li  class="c2"><span  class="c0">GR</span><span  class="c5 c0">50</span><span>,          the concentration at which the effect reaches a GR value of 0.5 based          on interpolation of the fitted curve.</span></li>      <li  class="c2"><span  class="c0">GR</span><span  class="c5 c0">inf</span><span           class="c0">&nbsp;</span><span>=        </span><span  class="c0">GR</span><span  class="c0">(c → inf)</span><span>,          which reflects asymptotic drug efficacy.</span></li>      <li  class="c2"><span  class="c0">GR</span><span  class="c5 c0">max</span><span>,          the effect at the highest tested concentration. Note that </span><span           class="c0">GR</span><span           class="c5 c0">max</span><span>&nbsp;can
          differ from </span><span  class="c0">GR</span><span  class="c5 c0">inf</span><span>&nbsp;if
          the dose response does not reach its plateau value.</span></li>      <li  class="c2"><span  class="c0">GEC</span><span  class="c5 c0">50</span><span>,          the drug concentration at half-maximal effect, which reflects the          potency of the drug.</span></li>      <li  class="c2"><span  class="c0">h</span><span  class="c5 c0">GR</span><span>,          Hill coefficient of the sigmoidal curve, which reflects how steep the          dose-response curve is.</span></li>      <li  class="c2"><span  class="c0">GR</span><span  class="c5 c0">AOC</span><span>,          the area over the dose-response curve, which is the integral of </span><span           class="c0">1–GR(c)</span><span>&nbsp;over
          the range of concentrations tested.</span></li>    </ul>    <p  class="c7"><span>&nbsp;</span></p>    <p  class="c7"><span>In addition, the online calculator reports the        r-squared of the fit and evaluates the significance of the sigmoidal fit        based on an F-test. Further information about these calculations is        available through our </span><span>GR tutorial</span><span>.</span></p>    <p  class="c6"><span></span></p>    <p  class="c7"><span>The results of analysis of existing LINCS dose-response        datasets using the GR model are available in the </span><span  class="c0">LINCS
        GR Data Browser</span><span>&nbsp;tab.</span></p>    <h2  class="c7 c14"  id="h.awowafiaa46j"><span>Analysis and visualization        tools:</span></h2>    <p  class="c7"><span>The following tabs allow users to analyze and visualize        their data and the calculated GR metrics.</span></p>    <p  class="c6"><span  class="c1"></span></p>    <ul  class="c18 lst-kix_qkescwycupop-0 start">      <li  class="c2"><span  class="c1">Data Tables </span><span>displays the</span><span>&nbsp;uploaded
          data and calculated GR values as well as the inferred GR metrics. Data          can be downloaded in .csv or .tsv format.</span></li>      <li  class="c2"><span  class="c1">Dose Response by Condition </span><span>plots
          the d</span><span>ata points and fitted dose-response curves for each          condition. If no specific conditions are selected, all data will be          overlaid on a single plot. To display a subset of the data, select          specific conditions to display (e.g. a specific cell line or drug).          Mousing over the plot displays the </span><span>GR values</span><span>&nbsp;and
          the corresponding concentration. Plots can be downloaded in a variety          of image formats.</span></li>      <li  class="c2"><span  class="c1">Dose Response Grid </span><span>shows          the fitted </span><span>dose-response curves side by side and grouped          according to the selected variables. ‘Selector variable’ and </span><span>‘grid
          variable’ define which plots are displayed</span><span>. ‘Selector          variable’ also defines the variable displayed in the selector box to          the left of the plots.</span></li>      <li  class="c2"><span  class="c1">GR Metric Comparison </span><span>shows          a s</span><span>catter plot of the a given GR metric across different          conditions. Users can select which metric to plot relative to which          experimental variable. Mousing over the plot displays the plotted GR          metrics. Plots can be downloaded in a variety of image formats.</span></li>    </ul>    <h2  class="c7 c14"  id="h.t551oewdm9gl"><span>Feedback</span></h2>    <p  class="c7"><span>We welcome </span><span>your feedback</span><span>&nbsp;on
        all of these tools and resources.</span></p>    <p  class="c6"><span></span></p>    <p  class="c7"><span>&nbsp;</span></p>    <p  class="c7"><span>-----</span></p>    <p  class="c6"><span></span></p>    <h1  class="c7 c14"  id="h.pc8qgt1osnze"><span>TAB 2.1: Getting Started</span></h1>    <p  class="c7"><span>&nbsp;</span></p>    <p  class="c7"><span  class="c20">For the Online GR Calculator Getting        Started tab:</span><span>&nbsp;(adapted from the ReadMe at</span><span><a           class="c16"           href="https://www.google.com/url?q=https://github.com/sorgerlab/gr50_tools&amp;sa=D&amp;ust=1460307175321000&amp;usg=AFQjCNFxsWjRUZl-MhqGaKI8xa_gqNx4AQ">&nbsp;</a></span><span         class="c19"><a           class="c16"           href="https://www.google.com/url?q=https://github.com/sorgerlab/gr50_tools&amp;sa=D&amp;ust=1460307175322000&amp;usg=AFQjCNGm0Lwa_VOnEtm_NQCNIC3XALQV_w">https://github.com/sorgerlab/gr50_tools</a></span><span>)</span></p>    <p  class="c7"><span>&nbsp;</span></p>    <p  class="c7"><span  class="c1">Step 1: Load the data file containing cell        counts for treated and control cells.</span></p>    <p  class="c7"><span  class="c1">&nbsp;</span></p>    <p  class="c7"><span>(Click </span><span  class="c0">Load Example</span><span>&nbsp;to
        the left to view a sample data file in the </span><span  class="c0">Data
        Tables</span><span>&nbsp;tab.)</span></p>    <p  class="c7"><span  class="c1">&nbsp;</span></p>    <p  class="c7"><span>To calculate normalized growth rate inhibition (GR)        values and corresponding metrics (</span><span  class="c0">GR</span><span         class="c5 c0">50</span><span         class="c0">,        GR</span><span  class="c5 c0">max</span><span  class="c0">, GEC</span><span         class="c5 c0">50</span><span         class="c0">,        GR</span><span  class="c5 c0">inf</span><span  class="c0">,</span><span>&nbsp;and
        Hill coefficient) based on cell counts measured in dose-response        experiments using this online tool, users must provide a tab-separated        (.tsv) data file in which each row represents a separate treatment        condition and the columns specify the keys (variables) that define the        treatment condition (e.g. cell line, drug or other perturbagen,        perturbagen concentration, treatment time, replicate) and the measured        cell counts (or surrogate such as CellTiter-Glo® or other readout). The        experimentally measured cell counts that are required for GR metric        calculation are as follows:</span></p>    <ul  class="c18 lst-kix_k1hefpyt8qdu-0 start">      <li  class="c2"><span>measured number of cells after perturbagen treatment          (defined as ‘cell count’, </span><span  class="c0">x(c)</span><span>)</span></li>      <li  class="c2"><span>measured number of cells in control wells (e.g.          untreated or DMSO-treated) on the same plate (defined as ‘control cell          count’, </span><span  class="c0">x</span><span  class="c5 c0">ctrl</span><span>)</span></li>      <li  class="c2"><span>measured number of cells from an untreated sample          grown in parallel until the time of treatment (defined as ‘time 0 cell          count’, </span><span  class="c0">x</span><span  class="c5 c0">0</span><span>)</span></li>    </ul>    <p  class="c7"><span>&nbsp;</span></p>    <p  class="c7"><span>The input .tsv file(s) must have the following column        headers (first row of the file):</span></p>    <p  class="c7"><span>&nbsp;</span></p>    <ul  class="c18 lst-kix_9dbpnvhyro1-0">      <li  class="c2"><span  class="c1">concentration</span><span>&nbsp;=          concentration of the perturbagen on which dose-response curves will be          evaluated</span></li>      <li  class="c2"><span  class="c1">cell_count</span><span>&nbsp;= the          measure of cell number (or a surrogate of cell number such as          CellTiter-Glo® staining) after treatment</span></li>      <li  class="c2"><span  class="c1">control cell count</span><span>&nbsp;in          a column labeled </span><span  class="c0">cell_count__ctrl</span><span>&nbsp;
          = the measure of cell number in control (e.g. untreated or          DMSO-treated) wells from the same plate</span></li>      <li  class="c2"><span  class="c1">time 0 cell counts</span><span>&nbsp;in          a column labeled </span><span  class="c0">cell_count__time0 </span><span>=          the measure of cell number in untreated wells grown in parallel until          the time of treatment</span></li>    </ul>    <p  class="c7"><span>&nbsp;</span></p>    <p  class="c7"><span>All other columns will be treated as additional key        variables (e.g. </span><span  class="c0">cell_line</span><span>, </span><span         class="c0">drug</span><span>,      </span><span  class="c0">time</span><span>, </span><span  class="c0">replicate</span><span>).
        </span></p>    <p  class="c7"><span  class="c1">&nbsp;</span></p>    <p  class="c7"><span  class="c1">Step 2: Select the grouping variables.</span></p>    <p  class="c7"><span  class="c1">&nbsp;</span></p>    <p  class="c7"><span>The key variables selected define on which variables        the GR values will be averaged before fitting of the dose-response        curves. By default, no variable needs to be selected, but, for example,        replicates can be averaged through selection of the proper column        header. </span></p>    <p  class="c6"><span></span></p>    <p  class="c7"><span  class="c1">&nbsp;</span></p>    <p  class="c7"><span>-----</span></p>    <p  class="c6"><span></span></p>    <h1  class="c7 c14"  id="h.q8wnmdwf2wlr"><span>TAB 3.1: Available Datasets</span></h1>    <p  class="c6"><span></span></p>    <h2  class="c7 c14"  id="h.vyu0yjtbjv9j"><span>LINCS Pilot Phase Joint        Project:</span></h2>    <p  class="c6"><span></span></p>    <p  class="c7"><span  class="c1">About this dataset</span></p>    <p  class="c7"><span  class="c1">&nbsp;</span></p>    <p  class="c7"><span>The dose-dependent sensitivities of 6 nonmalignant        breast and breast cancer cell lines were assayed by the HMS LINCS Center        by measuring cell counts 72 hours after treatment with each of 107 small        molecule inhibitors across a 6-point dose range. For further information        about the assay and to download this dataset (</span><span  class="c19"><a           class="c16"           href="https://www.google.com/url?q=http://lincs.hms.harvard.edu/db/datasets/20252/&amp;sa=D&amp;ust=1460307175330000&amp;usg=AFQjCNHMuFufDxCbGB3eC0x12T6WXFFkbA">#20258</a></span><span>)        or the cell count datasets from which the metrics were calculated (</span><span         class="c19"><a           class="c16"           href="https://www.google.com/url?q=http://lincs.hms.harvard.edu/db/datasets/&amp;sa=D&amp;ust=1460307175331000&amp;usg=AFQjCNGFn_6Q2WIbPdpVm_opa3WOUi-8ng">#20245
          to #20251</a></span><span>), please visit the HMS LINCS Database.</span></p>    <p  class="c6"><span></span></p>    <h2  class="c7 c14"  id="h.ohnd5u8rteik"><span>LINCS Phase II MCF10A Common        Project: </span></h2>    <p  class="c6"><span></span></p>    <p  class="c7"><span  class="c1">About this dataset</span></p>    <p  class="c6"><span></span></p>    <p  class="c7"><span>As a pilot study for the LINCS MCF 10A Common Project,        the dose-dependent sensitivity of a common isolate of the nonmalignant        breast cell line MCF 10A was assayed independently by 4 of the LINCS        Data and Signature Generation Centers by measuring cell counts or by        estimating proliferation using the CellTiter-Glo® assay 72 hours after        treatment with each of 8 small molecule inhibitors across a 9-point dose        range.</span></p>    <p  class="c6"><span></span></p>    <h2  class="c7 c14"  id="h.47s22j3tm75j"><span>HMS LINCS Reanalysis of        Heiser et al. (2012):</span></h2>    <p  class="c6"><span></span></p>    <p  class="c7"><span  class="c1">About this dataset</span></p>    <p  class="c7"><span  class="c1">&nbsp;</span></p>    <p  class="c7"><span>The dose-dependent sensitivities of 74 nonmalignant        breast and breast cancer cell lines were assayed by estimating        proliferation using the CellTiter-Glo® assay 72 hours after treatment        with each of ~100 small molecule inhibitors across a 9-point dose range.        These data were collected by the laboratory of Dr. Joe Gray (Oregon        Health Sciences University), and analysis of the data using traditional        growth inhibition metrics (GI</span><span  class="c5">50</span><span>)        was reported in </span><span  class="c19"><a  class="c16"  href="https://www.google.com/url?q=http://dx.doi.org/10.1073/pnas.1018854108&amp;sa=D&amp;ust=1460307175335000&amp;usg=AFQjCNF1JklQh7CdOZcu8InTiFIzWNzGcw">Heiser
          et al. (2012)</a></span><span>. Here, the HMS LINCS Center reports the        GR metrics for the data.</span></p>    <p  class="c6"><span></span></p>    <h2  class="c7 c14"  id="h.12w3hzczbras"><span>HMS LINCS Seeding Density        Project:</span></h2>    <p  class="c6"><span></span></p>    <p  class="c7"><span  class="c1">About this dataset</span></p>    <p  class="c7"><span  class="c1">&nbsp;</span></p>    <p  class="c7"><span>The density- and context-dependent sensitivities of 6        breast cancer cell lines plated at 6 different cell densities were        assayed by the HMS LINCS Center by measuring cell counts 72 hours after        treatment with each of 12 small molecule inhibitors across a 9-point        dose range. For further information about the assay and to download the        GR metrics dataset (</span><span  class="c19"><a  class="c16"  href="https://www.google.com/url?q=http://lincs.hms.harvard.edu/db/datasets/20258/&amp;sa=D&amp;ust=1460307175337000&amp;usg=AFQjCNFuZUgU_i6QQ0uauzkbE2BLpOLQbQ">#20258</a></span><span>)        or the cell count datasets from which the metrics were calculated (</span><span         class="c19"><a           class="c16"           href="https://www.google.com/url?q=http://lincs.hms.harvard.edu/db/datasets/20256/&amp;sa=D&amp;ust=1460307175338000&amp;usg=AFQjCNHfX6XM43WLrtlYeRYFkLK5NdvasQ">#20256</a></span><span>&nbsp;and
        </span><span  class="c19"><a  class="c16"  href="https://www.google.com/url?q=http://lincs.hms.harvard.edu/db/datasets/20257/&amp;sa=D&amp;ust=1460307175339000&amp;usg=AFQjCNEc6fypXTh5sj58Zk9wFp-ZFKPmqA">#20257</a></span><span>),
        please visit the HMS LINCS Database.</span></p>    <p  class="c6"><span></span></p>    <p  class="c6"><span></span></p>  </body></html>